Fundraising Fox

Liminatus Pharma

NASDAQ: LIMN

Fullerton, US · Delaware corporation

Biotech

Founders & leadership

BC
Byong C. YooExecutive
CK
Chris KimExecutive
SD
Sang-jin Daniel LeeExecutive
SD
Scott DamExecutive
BK
Beom K. ChoiExecutive

Board

ES
Eun Sook LeeBoard director
NF
Nicholas FernandezBoard director
JY
Ji Yeon BaekBoard director

Reported raises · per SEC filings

Form D private placements

$1.9M disclosed across 1 of 2 rounds · 2025–2026

▶$1.9MraisedJun 2026 · 1 investors · Pharmaceuticals
Rule 506(b)
Liminatus Pharma raises $1.9M in warrant exercise | LIMN Stock Newsstocktitan.net · Jun 2026Form 4 Liminatus Pharma Inc For: 6 July By Investing.comca.investing.com · Jul 2026
Officers, directors & promoters on the filing
  • Nicholas FernandezDirector
  • Ji Yeon BaekDirector
  • Byong C. YooExecutive Officer
  • Chris KimExecutive Officer, Director
  • Eun Sook LeeDirector
  • Sang-jin Daniel LeeExecutive Officer
  • Scott DamExecutive Officer
  • Beom K. ChoiExecutive Officer
Offering amount
$1.9M
Amount sold
$1.9M
Sales commissions
$149K
Placement agents
Maxim Group LLC
First sale
Jun 2026
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

Form 4 Liminatus Pharma Inc For: 6 July By Investing.comca.investing.com · Jul 2026Liminatus (NASDAQ: LIMN) resale S-1 and 1.6B-share InnocsAI merger planstocktitan.net · Jun 2026Liminatus Pharma raises $1.9M in warrant exercise | LIMN Stock Newsstocktitan.net · Jun 2026Liminatus Pharma, Inc. announced that it has received $15 million in funding | MarketScreenermarketscreener.com · Apr 2025

Frequently asked questions

How much funding has Liminatus Pharma raised?
Liminatus Pharma has disclosed $1.9M raised across 1 of its 2 known rounds.
Where is Liminatus Pharma headquartered?
Liminatus Pharma is headquartered in Fullerton, US.